Company intelligence / Profile preview

The Maren Group

Gainesville, FL, USA

Ownership: Private
Development stage: Other

Overview

The Maren Group is a boutique strategic advisory and investment banking firm exclusively dedicated to the life sciences, biotechnology, and healthcare sectors. The firm specializes in providing high-level consultancy for mergers and acquisitions (M&A), licensing agreements, and corporate development strategies. Founded to leverage the legacy of Dr. Thomas Maren, the inventor of the glaucoma medication Trusopt, the firm maintains deep expertise in the commercialization of therapeutic assets. The Maren Group assists both emerging and established biopharmaceutical companies in navigating complex deal structures and maximizing the value of their intellectual property. Their services bridge the gap between innovative scientific research and successful market execution or capital events.

Industry: Consulting

Beyond the preview

Go deeper on The Maren Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Maren Group.

Explore the full profile